Yellowstone Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$1.17M Buy
8,368
+245
+3% +$34.1K 0.66% 34
2017
Q3
$1.06M Buy
+8,123
New +$1.08M 0.55% 42
2016
Q3
$1.37M Sell
11,562
-2,890
-20% -$351K 0.5% 54
2016
Q2
$1.75M Sell
14,452
-3,415
-19% -$388K 0.75% 28
2016
Q1
$1.93M Sell
17,867
-850
-5% -$88K 0.83% 25
2015
Q4
$1.92M Sell
18,717
-621
-3% -$62.5K 0.87% 22
2015
Q3
$1.8M Buy
19,338
+3,392
+21% +$328K 0.85% 23
2015
Q2
$1.55M Buy
15,946
+721
+5% +$72.2K 0.7% 27
2015
Q1
$1.53M Buy
15,225
+100
+0.7% +$10.2K 0.77% 30
2014
Q4
$1.58M Buy
15,125
+989
+7% +$104K 0.85% 24
2014
Q3
$1.51M Buy
14,136
+1,262
+10% +$131K 0.85% 26
2014
Q2
$1.35M Buy
12,874
+394
+3% +$39.8K 0.79% 27
2014
Q1
$1.23M Buy
12,480
+224
+2% +$20.8K 0.77% 24
2013
Q4
$1.12M Buy
+12,256
New +$1.13M 0.72% 30

Other funds holding JNJ

Yellowstone Partners's JNJ Position: Q4 2017 in Review

Yellowstone Partners increased its Johnson & Johnson (JNJ) stake by 3% in Q4 2017, buying an estimated $34.1K and bringing the position to 8,368 shares worth $1.17M. The position accounts for 0.66% of the portfolio, ranked #34.

Yellowstone Partners first reported a position in JNJ in Q4 2013 and has held it in 14 quarters since. The position peaked at $1.93M in Q1 2016. 2,623 funds tracked by Wall St. Rank hold JNJ as of Q4 2017.

  • Yellowstone Partners held 8,368 shares of Johnson & Johnson worth $1.17M as of Q4 2017.
  • Yellowstone Partners bought 245 Johnson & Johnson shares in Q4 2017, an estimated $34.1K.
  • Johnson & Johnson made up 0.66% of Yellowstone Partners's portfolio in Q4 2017, its #34 holding.
  • Yellowstone Partners first reported a position in Johnson & Johnson in Q4 2013 and has held it in 14 quarters since.
  • Yellowstone Partners's Johnson & Johnson position peaked at $1.93M in Q1 2016.
  • 2,623 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2017.

Based on Yellowstone Partners's 13F filing for Q4 2017, filed 24 Jan 2018.